These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13833206)

  • 1. On the reported inhibition of monoamine oxidase by an agent with sedative properties.
    SPECTOR S; SHORE PA; BRODIE BB
    Science; 1960 Sep; 132(3429):735. PubMed ID: 13833206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase, psychoenergizers, and tranquilizers.
    FELDSTEIN A; HOAGLAND H; FREEMAN H
    Science; 1959 Aug; 130(3374):500. PubMed ID: 13822065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of 1-benzyl-2-methyl-5-methoxytryptamine on monoamine oxidase.
    ZELLER EA
    Science; 1960 Dec; 132(3440):1659. PubMed ID: 13788169
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
    WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
    [No Abstract]   [Full Text] [Related]  

  • 5. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
    Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [EFFECT OF ALPHA-SUBSTITUTED BETA-(2-METHYL-3-INDOLYL)-PROPIONIC ACID HYDRAZIDES ON THE ACTIVITY OF BRAIN MONOAMINO OXIDASES].
    SAFRAZBEKIAN RR; SUKASIAN RS
    Farmakol Toksikol; 1964; 27():213-7. PubMed ID: 14193091
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition "in vitro" of monoamine oxidase].
    NARANJO R
    Rev Asoc Medica Mex; 1960 Jun; 40():272-9. PubMed ID: 14426018
    [No Abstract]   [Full Text] [Related]  

  • 8. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A
    Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH; HORITA A
    J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific liver and brain monoamine oxidase inhibition by alkyl- and arylalkylhydrazines.
    HORITA A; McGRATH WR
    Proc Soc Exp Biol Med; 1960 Apr; 103():753-7. PubMed ID: 14403108
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A
    Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the active center of monoamine oxidase.
    ZELLER EA
    Experientia; 1960 Sep; 16():399-402. PubMed ID: 13788171
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of relationship between inhibition of monoamine oxidase and potentiation of hexobarbital hypnosis.
    LAROCHE MJ; BRODIE BB
    J Pharmacol Exp Ther; 1960 Oct; 130():134-7. PubMed ID: 13759147
    [No Abstract]   [Full Text] [Related]  

  • 14. Accumulation of serotonin in the brain of reserpine-treated mice after inhibition of monoamine oxidase: effect of body temperature.
    DUBNICK B; LEESON GA; CHESSIN M; SCOTT CC
    Arch Int Pharmacodyn Ther; 1960 Jun; 126():194-202. PubMed ID: 13818306
    [No Abstract]   [Full Text] [Related]  

  • 15. Some remarks about monoamine oxidase and monoamine oxidase inhibitors.
    ZELLER EA
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():125-30. PubMed ID: 13788170
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological properties of a new inhibitor of monoamine oxidase: 2-hydrazino-1-phenylpropane].
    GENOVESE E; ARRIGONI-MARTELLI E; FRESIA P
    Farmaco Sci; 1959 Jul; 14():516-26. PubMed ID: 13849925
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of psychotropic compounds on enzyme systems. I. In vitro inhibition of monoamine oxidase.
    USDIN E; USDIN VR
    Proc Soc Exp Biol Med; 1961 Nov; 108():461-3. PubMed ID: 13923955
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine oxidase inhibition.
    ROSENBLUM I; FERGUSON FC
    Clin Pharmacol Ther; 1960; 1():692-3. PubMed ID: 13743428
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic aspects of monoamine oxidase inhibition.
    WEBB JL
    Am J Cardiol; 1960 Dec; 6():1112-6. PubMed ID: 13783566
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of brain monoamine oxidase by some CNS depressants.
    Bellin JS; Sorrentino GM
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):673-80. PubMed ID: 4456499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.